Location History:
- Park Ridge, IL (US) (2014 - 2024)
- Chicago, IL (US) (2018 - 2024)
Company Filing History:
Years Active: 2014-2025
Title: Innovator Spotlight: Suzanne D. Conzen
Introduction
Suzanne D. Conzen is a prominent inventor based in Park Ridge, IL, known for her significant contributions to the field of cancer research. With a total of 14 patents to her name, she has made remarkable advancements in the understanding and treatment of breast cancer.
Latest Patents
Among her latest patents, two noteworthy inventions focus on glucocorticoid receptor antagonists and their application in breast cancer therapies. The first patent discusses methods and compositions related to glucocorticoid receptor antagonists, specifically aimed at determining the prognosis of breast cancer patients by evaluating glucocorticoid receptor activity in tumor cells. Additionally, it addresses treatment methods for breast cancer cells, particularly those that are chemo-resistant, using glucocorticoid receptor antagonists in conjunction with anticancer agents. The second patent is dedicated to triple-negative breast cancer, outlining kits and methods for treating patients deemed susceptible to glucocorticoid receptor antagonist therapy, with or without additional anticancer compounds.
Career Highlights
Suzanne D. Conzen's career is highlighted by her work at the University of Chicago, where she continues to engage in pioneering research aimed at improving treatment outcomes for breast cancer patients. Her patents reflect her dedication to advancing medical science and her commitment to addressing urgent health issues.
Collaborations
Suzanne has had the privilege of collaborating with esteemed colleagues, including Deng Pan and Masha Kocherginsky. These partnerships have enriched her research and contributed to the innovative methodologies she has developed throughout her career.
Conclusion
In conclusion, Suzanne D. Conzen stands out as a leading figure in the field of breast cancer research. Her inventions not only showcase her expertise but also hold the potential to significantly impact patient care and treatment strategies. As she continues her work, the medical community eagerly anticipates the future advancements that will stem from her innovative approach.